Since the first report of a subtype of sinonasal carcinoma characterized by a deficiency of the SMARCB1 gene in 2014 to date, fewer than 200 cases have been reported. This evidence concerns the gene SMARCB1 and nasal cavity and paranasal sinus carcinoma.